Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What about the significance of the CTO posted by SuperB, and all the other patents?
Thank you.
Final shakes
With bleed out clauses and can be paid off. Don’t forget the rest of the questions. And, what is different here than any other start up anyway? You are losing me here. They all have notes.
We are going through commercialization to get started up. Nothing new here. And we have talked about the cap of the OS even if ALL converted. No issues.
Revs coming in!!! Selling kits by the scores. As you pointed out, worse case scenario these are gone soon.
Yup, but don’t forget those are in much friendlier hands, and have MUCH better terms and some have been renegotiated. AND they can be paid off. Nothing compared to the terrible note done today. What you say about StemSpine and AmnioStem? Lots of room for growth?
Profit is profit. I will see plenty here as these doctors keep signing up and bringing in revs. No doubt Q1 will be decent with Rome and NM buying scores of empty boxes LOLOL
I bet we see Sanderson up and running in May, OH, TN, TX and maybe more in June.
I also think once they hit their sweet spot with what they think is enough offices opening, the gloves will come off and it will be heavily marketed.
Right now they don’t have enough offices open (IMO) to spend the money. If they did they would need more notes, and NO ONE wants that. Well maybe 3-4 do, ha And it would be a waste if most folks don’t have an office within a days drive anyway.
Revs will kick in, advertising and the TV ads kick in and we will see where this company can run too.
Like we have posted before, 20 offices just cranking out one procedure a day, CaverStem or FemCelz, and revs start piling in.
It’s all happening right before our eyes!
Thanks for the heads up, I will try to grab them.
What’s your thought on the other patents and StemSpine and AmnioStem? Lots of arrows in the quiver, don't ya think?
That’s a first...LOL. So many things happening with CELZ. This won’t be kept down long and may run when we see a huge change from Q1 2018 - Q1 2019. Not to mention a nice bump from Q4 2018. In 2018 about all we had was LA, now several location are rolling along nicely and a couple are rocking it. It’s just a matter of when this gets picked up by new money.
Not me, but I doubled down ;)
Agreed. I am sure if any note is left it will clear today and I am sure the MM will shake it hard first.
Fully agree Diegote10. CELZ has many things happening. The Q could get the ball rolling even faster!
Or like the last trade today. Ask was .007 and they filled it at .00688. My buy today showed up as a sell. SMH
When the buying picks up we will see :)
We talk about this off camera all the time. Juts that the MM’s are hiding them.
Cash, i would agree with rrao. If I read the filings correctly, that note holder has until tomorrow to sell his shares. I assume, like all of us, he expected the PPS to be higher, but at the 11th hour he had to dump them. That was much of the volume last week and the day traders piling on. If he has any left to go, we will know by tomorrow.
Retail is sitting and watching for an entry point. Some, like me, waiting for him to sell out and I can grab as low as possible. Others may be waiting on the revs. The low volume tells me he is done, or hoping for a bump up himself.
There is no doubt Q1 2019 will be much higher than Q1 2018 showing a nice increase. How the market reacts will be known soon.
What’s your take on StemSpine and AmnioStem?
If CaverStem and FemCelz roll out faster and faster as we have seen these last couple months, which will bring in enough revs to stop the notes, and StemSpine rolls out by 2020 followed by AmnioStem.......
I think multiple pennies by the end of the year....08+, dimes or quarters next year, and dollars in 3-5 years.
If all of these come together the SS is fine.
I also hope that revs kick in this summer to buy back the remaining notes. I think that is why they pushed them out until 2020, but that is just a guess. None of the notes were that big, just a couple hundred thousand each.
Antonini alone used 60 kits brining in tens of thousands in revs. Add in NM and Narayan, Gershman, Liu and HI, TX, TN, OH etc etc, it’s not far fetched to see the potential to ramp up revs pretty quick...FINALLY
And don’t forget we have doubled the pool of potential patients with FemCelz. A few doctors have already treated with FemCelz so we know there is a demand!
No doubt CELZ stumbled and fell last fall, but they are back on their feet and about to start running IMO.
From another long many months ago....$CELZ boasts Dr. Amit N. Patel, MD, who is Associate Professor & Director-Tissue Engineering at University of Utah. He is A co-founder of $CELZ and serves on the Board of Directors for Creative Medical Technology Holdings, Inc., HUGE IMPACT PLAYER for #StemSpine. Huge potential! spot on IMO
Looks like NSX was spot on here. I bet the StemSpine info is spot on too. https://investorshub.advfn.com/boards/read_msg.aspx?message_id=144202177
What is so cool is that our favorite ticker, CELZ, is working on StemSpine another regenerative stem cell treatment. From a medical point of view, I can barely wait until it’s available. And from an investment standpoint, well, it’s another revenue stream coming sooner than later.
"StemSpineTM is expected to launch in late 2019. We feel it is in the best interest of the company to dedicate much of our resources to continue to build those brands and our cash flow before commercializing StemSpine."
What about the significance of the CTO posted by SB, and all the other patents?
CELZ is MUCH more than CaverStem and FemCelz. They are just the start, soon to be followed by StemSpine and AmniStem and more.
We have gone over ad nauseum how we got to where we are trading now. NOW is the time to get in or average down as it is crystal clear to me this is all finally coming together. IMO
I almost hope the salmon are right and we dip as the note holder exits by May 14, I would love to top off just a bit more before launch.
Ton... if the toxic note holder has until COB tomorrow to sell, you bet he is. Simple as that. We will know starting Wednesday. Add to that, anyone wanting to flip can take advantage and pile on so to say.
There is zero doubt in my mind that we will see many more US doctors and overseas doctors signing up and ramping up revs all summer.
That’s why I am comfortable adding here and holding long. Several longs had good informative posts over the weekend explaining their DD. The others can only say everyone is lying from the top down. You only have to use simple logic to know who is right.
Long and strong!
Adding :) These notes clearing won’t last past May 14 ;)
Wolf, go back and read the filings. It will make you feel better. Its all there in black and white.
Exactly. This Q will be nothing more than evidence of what the longs have been saying...... that the company is just starting out, and after a few trips and falls is up and running. Doctors are coming on board and being trained in CaverStem 2.0 and FemCelz at a much quicker pace. There is ample evidence for anyone who truly wants to see it, that needle kits are being sold by scores.
Revs are revving up and this Q will be the best Q......so far. Simple logic will tell you that Q2 will be bigger and that Q3 will be even bigger, and so on for the foreseeable future. Like many have said, if you hold long enough, you can literally buy for pennies on the dollar.
That is how I see it too superbingo. Especially after seeing the excitement from the doctors. This is not just some new product or choice to add to a list of others. Early indications are that it is the FIX they have been looking for. Pretty damn cool to be in during the beginning!
If CaverStem and FemCelz roll out faster and faster as we have seen these last couple months, which will bring in enough revs to stop the notes, and StemSpine rolls out by 2020 followed by AmnioStem.......
I think multiple pennies by the end of the year, dimes next year, and dollars in 3-5 years.
If all of these come together the SS is fine.
I also hope that revs kick in this summer to buy back the remaining notes. I think that is why they pushed them out until 2020, but that is just a guess. None of the notes were that big, just a couple hundred thousand each.
Antonini alone used 60 kits brining in tens of thousands in revs. Add in NM and Narayan, Gershman, Liu and HI, TX, TN, OH etc etc, it’s not far fetched to see the potential to ramp up revs pretty quick...FINALLY
And don’t forget we have doubled the pool of potential patients with FemCelz. A few doctors have already treated with FemCelz so we know there is a demand!
No doubt CELZ stumbled and fell last fall, but they are back on their feet and about to start running IMO.
Happy Mother’s Day to the CELZ Moms!!!!
Eternal DD, not hope. I go over it instead of hoping. The odds are heavily stacked in my favor for all the reasons we discussed today. you are probably sincere about your belief. Good luck to you.
That’s a keeper, thanks! .0001 OMG
Agreed Chaka. Every Q for the past 4 (soon to be 5) have been increasing. The revenues in 2019 will CLEARLY be far better than 2018. With all the “products” coming down the pipeline, you are no doubt spot on. Q after Q for the foreseeable future will rock. Other than saying they are lying about it all, and had some crap notes that are gone this week, there is little more to argue.
Nice analogy. Agreed. The radio silence (really, monthly updates) are by design. Sadly, they are keeping their shareholders in the dark, but they are keeping their adversaries off balance too. All that will change soon, all IMHO.
Thanks for the reply Wolf. I could debate each point you made, but I will refrain......for now. (Biting tongue).